LEADER 02050nam  2200529   450 
001 9910787593203321
005 20230803030607.0
010   $a1-78084-168-X
035   $a(CKB)2670000000391299
035   $a(EBL)1179660
035   $a(OCoLC)851970669
035   $a(SSID)ssj0001599939
035   $a(PQKBManifestationID)16306723
035   $a(PQKBTitleCode)TC0001599939
035   $a(PQKBWorkID)14892847
035   $a(PQKB)10009020
035   $a(MiAaPQ)EBC1179660
035   $a(Au-PeEL)EBL1179660
035   $a(OCoLC)828119265
035   $a(EXLCZ)992670000000391299
100   $a20220517d2013      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aOsteoporosis /$feditors, Jean-Yves Reginster and Olivier Bruye?re
205   $a1st ed.
210  1$aLondon, England :$cFuture Medicine Ltd.,$d[2013]
210  4$dİ2013
215   $a1 online resource (88 p.)
300   $aDescription based upon print version of record.
311   $a1-78084-170-1 
327   $aTitle page; Copyright page; Contents; Foreword. Osteoporosis; 1. Pathogenesis of osteoporosis; 2. Diagnosis of osteoporosis; 3. Nonmedical treatment of osteoporosis; 4. Pharmacological treatment of osteoporosis; 5. Preventing postmenopausal osteoporosis; Index
330   $aOsteoporosis is considered to be a major health issue in all developed countries, but recent years have seen improvements in understanding and management of the disorder. This work, authored by a team of international experts, explores the pathogenesis and diagnosis of disease, available treatments (pharmacological and non-medical) together with options for prevention.
606   $aOsteoporosis
615  0$aOsteoporosis.
676   $a616.716
702   $aReginster$b Jean-Yves
702   $aBruye?re$b Olivier
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910787593203321
996   $aOsteoporosis$91014999
997   $aUNINA